研報掘金丨國信證券:首予中國稀土“優於大市”評級,後續有較為明確的整合預期
國信證券研報指出,中國稀土是中稀集團核心上市平台,業績與稀土價格相關性強。2024年稀土價格跌幅較大,公司全年歸母淨利潤-2.87億元(-168.69%);2025Q1歸母淨利潤0.73億元(同環比扭虧)。公司於2025年5月的公吿中也表示正積極配合集團開展解決同業競爭問題的工作,擇機開展併購重組。目前集團有中稀江西(原贛州稀土)等多個下屬子公司與公司存在同業競爭問題,公司後續有較為明確的整合預期。考慮到公司作為中稀集團核心上市平台,有較強整合預期,首次覆蓋給與“優於大市”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.